|Bid||30.48 x 900|
|Ask||30.53 x 800|
|Day's Range||28.61 - 30.81|
|52 Week Range||25.04 - 64.37|
|Beta (5Y Monthly)||1.08|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Ionis Pharmaceuticals (IONS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Ionis (IONS) incurs wider-than-expected Q3 loss. The company maintains its top-and bottom-line guidance for 2021
IONS earnings call for the period ending September 30, 2021.